Plexus Corp. SEC Filing - Quarterly Report (10-Q) January 31, 2025 See All News » Investing Groups Covering PLXS Value In Corporate Events The Value Investor Themes: Value Event Driven Latest on PLXS:Plexus - Likely Temporary Softness ...
Plexus Corp (PLXS) 125.83 +0.37 (+0.29%) 05/07/25 [NASDAQ] Quote Overview for Wed, May 7th, 2025 Notes Alerts Watch Help Day Low 124.75 Day High 126.55 Open 126.26 Previous Close 125.46 Volume 131,400 Avg Vol 176,340 Stochastic %K 58.12% Weighted Alpha +6.74 5-Day ...
Xellia Pharms APS Kisqali™ is indicated in combination with an aromatase inhibitor as initial endocrine-based Novartis Pharms Corp therapy for the treatment of postmenopausal women with hormone receptor (HR)-positive, hu- man epidermal growth factor receptor 2 (HER2)- negative advanced or ...
Plexus Corp. Annual stock financials by MarketWatch. View the latest PLXS financial statements, income statements and financial ratios.
Plexus (PLXS) Down 8.9% Since Last Earnings Report: Can It Rebound? Feb. 21, 2025 at 11:30 a.m. ET on Zacks.com Top Plexus Executive Cashes In Big on Stock Sale! Feb. 18, 2025 at 9:09 p.m. ET on TipRanks.com Plexus Corp (PLXS) to Participate in Raymond James 46th...
This Plexus Policy is applicable to all global Plexus locations included, but not limited to the following: Plexus Corp. Limited (SC207257). Plexus Corp (UK) Limited (SC146948). Plexus Corp. Services (UK) Limited (SC468114)
PLEXUS SUPPLIER CODE OF CONDUCT Plexus Corp. and its affiliate companies ("Plexus"), is committed to upholding high standards of ethics, integrity and corporate social responsibility in our business operations. In part, this is demonstrated through our membership in the Responsible Business Allian...
PremiumCharting a flat response to Apple’s report Apr. 24, 2014 at 10:52 a.m. ETby Michael Ashbaugh Wednesday’s biggest movers; Boeing sheds over 2% Nov. 7, 2012 at 4:34 p.m. ETby Barbara Kollmeyer Plexus Corp. Plexus Corp. engages in the provision of electronic manufacturing servic...